Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Transjugular Intrahepatic Portosystemic Shunt Creation with 1 Modified Portal Vein Access Site may Decrease Significant 2 change in Hepatic Encephalopathy: Single Centre Outcomes

Abstract

Abstract Introduction: We aimed to assess whether Transjugular Intrahepatic Portosystemic Shunt (TIPS) creation via Peripheral Right Portal Vein access (P-RPV), which was considered the classic portal vein access site in TIPS creation, was associated with more severity of post-TIPS HE compared to the Other Portal Vein access (O-PV) which was named the modified portal vein access site. Methods: This was an IRB-approved single-institution retrospective study. Consecutive patients with cirrhosis who underwent technically successful TIPS creation were reviewed. Patients were assigned to two groups: P-RPV group and O-PV group. The primary outcome was a clinically significant change in Hepatic Encephalopathy (ΔHE). Secondary outcomes included survival, stent patency, de novo HE, Overt HE (OHE, grades 2-4), rebleeding and ascites control. Predictors of significant ΔHE and overall survival were identified using Cox regression models. Results: 328 patients were reviewed, and 230 patients were assigned to the P-RPV group (n=66) or the O-PV group (n=164). The incidence of ΔHE was 11 (17%), 14 (24%), 14 (25%) and 15 (30%) patients in the P-RPV group and 11 (8%), 13 (9%), 15 (12%) and 15 (12%) patients in the O-PV group at 30 days (p=0.03), 90 days (p=0.007), 180 days (p=0.03) and 365 days (p=0.005), respectively. P-RPV shunt location (HR, 3.11; 95% CI 1.35-7.14; p=0.008), HE before TIPS (HR, 2.47; 95% CI 1.10-5.55; p=0.03), TIPS patency (Year) (HR, 0.76; 95% CI 0.64-0.91; p=0.003) and 10 mm Viatorr stent-graft (HR, 0.09; 95% CI 0.20-0.44; p=0.003) were independently associated with significant ΔHE after TIPS. Our results did not show an association between survival and HE before TIPS (HR, 1.29; 95% CI 0.89-1.87; p=0.17). Conclusion: TIPS with O-PV access may decrease significant ΔHE. The presence of HE before TIPS is associated with an increased risk of significant ΔHE after the procedure; however, it does not impact patient survival. Right atrial pressure after TIPS is a critical determinant of patient prognosis. Significant ΔHE may serve as a reliable indicator for evaluating HE following TIPS.

Keywords

Top